Jonathan Dranoff is a Gastroenterology physician. OpenAlex indexes 142 publications with 3,412 citations (h-index 31); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4301 W Markham St # 567
Shorey S8/68
Little Rock, AR 722057101
Telephone
501-688-7840Registry record last updated 13 Apr 2011.
Clinical trials
- The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study
Sponsor: University of Arkansas
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
52%Rifamycin Antibacterial17.3%Xifaxan100%Part D<11 patientsBile Acid17.3%Ursodiol100%Part D<11 patients+ 1 more class in this area
Cardiovascular
48%Aldosterone antagonist (MRA)30.7%Spironolactone100%Part D<11 patientsBeta blocker17.3%Propranolol Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2010–2015 per NIH RePORTER. The latest:
- Regulation of hepatic stellate cells by intracellular calcium
Univ of Arkansas for Med Scis
FY2015$298,000R56DK076735 - Regulation of Hepatic Stellate Cells by Extracellular Nucleotides
Univ of Arkansas for Med Scis
FY2012$306,939R01DK076735 - Regulation of Hepatic Stellate Cells by Extracellular Nucleotides
Univ of Arkansas for Med Scis
FY2011$296,852R01DK076735
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis
Digestive Diseases and Sciences
2022 - Short‐Term Safety of Repeated Acetaminophen Use in Patients With Compensated Cirrhosis
Hepatology Communications
2021 - Fibroblast Growth Factor-21 to Adiponectin Ratio: A Potential Biomarker to Monitor Liver Fat in Children With Obesity
Frontiers in Endocrinology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Charles Rice, MD
The Rockefeller University
Kris Kowdley, MD
Washington State University
Eamonn Quigley, MD
Houston Methodist Hospital and Academic Institute
Patrick Kamath, MD
Mayo Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”